Angiogenesis in primary and metastatic epithelial ovarian carcinoma


      Objective: Our goal was to evaluate angiogenesis in the ovaries and omental metastases as a prognostic indicator in patients with epithelial ovarian carcinoma. Study design: Ovarian specimens of 42 consecutive patients with primary epithelial ovarian carcinoma (stages I to IV) and omental metastases of 19 of these patients with stage IIIB or stage IIIC disease were stained immunohistochemically for factor VIII–related antigen. Microvessel counts were tested for correlation with patient age, stage of disease, type of tumor, preoperative serum CA 125 level, tumor size, tumor resectability, patient survival, and omental microvessel counts. Statistical analysis included parametric (factorial analysis of variance) and nonparametric (Mann-Whitney and Kruskal-Wallis) group comparison tests, parametric (Pearson) and nonparametric (Spearman) correlation tests, and parametric (Cox proportional hazards) and nonparametric (Kaplan-Meier) survival analysis with p < 0.05 considered significant throughout. Results: Microvessel counts of omental metastases in patients with stage IIIB or stage IIIC ovarian carcinoma were significantly correlated with preoperative serum CA 125 level (p = 0.028) and patient survival (p = 0.019). Microvessel counts of the ovaries examined were not correlated with patient age, stage of disease, type of tumor, preoperative serum CA 125 level, tumor size, tumor resectability, patient survival, or microvessel count of the corresponding omental metastases. Conclusion: Microvessel count of omental metastases is an independent prognostic indicator of survival in patients with advanced epithelial ovarian carcinoma and correlates with preoperative serum CA 125 level.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Folkman J.
        Tumor angiogenesis.
        Adv Cancer Res. 1985; 43: 175-203
        • Folkman J.
        What is the evidence that tumors are angiogenesis dependent?.
        J Natl Cancer Inst. 1990; 82: 4-6
        • Folkman J.
        Clinical application of research on angiogenesis.
        N Eng J Med. 1995; 333: 1757-1763
        • Strivastava A
        • Laidler P
        • Davies RP
        • Horgan K
        • Hughes LE
        The prognostic significance of tumor vascularity in intermediate thickness (0.76-4mm thick) skin melanoma.
        Am J Pathol. 1988; 133: 413-423
        • Weidner N
        • Semple JP
        • Welch WR
        • Folkman J.
        Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma.
        N Engl J Med. 1991; 324: 1-8
        • Dickinson AJ
        • Fox SB
        • Persad AA
        • Hollyee J
        • Sibley GN
        • Harris AL.
        Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder cancer.
        Br J Urol. 1994; 74: 762-766
        • Weldher N
        • Carroll PR
        • Flax J
        • Blimenfeld W
        • Folkman J.
        Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
        Am J Pathol. 1993; 143: 401-409
        • Macchiarini P
        • Fontani G
        • Hardin MJ
        • Squartini F
        • Angeletti CA.
        Relation of neovascular to metastasis of non-small cell lung cancer.
        Lancet. 1992; 340: 145-146
        • Olivarez D
        • Wilbroght T
        • DeRiese W
        • Foster R
        • Reister T
        • Einhorn L
        • et al.
        Neovascularization in clinical stage A testicular germ cell tumor prediction of metastatic disease.
        Cancer Res. 1994; 54: 2880-2882
        • Wiggins DL
        • Granai CO
        • Steinhoff MM
        • Calabrewsi P.
        Tumor angiogenesis as a prognostic factor in cervical carcinoma.
        Gynecol Oncol. 1993; 56: 353-356
        • Kirschner CV
        • Alanis-Amezcua JM
        • Martin VG
        • Luna N
        • Morgan E
        • Yang JJ
        • et al.
        Angiogenesis factor in endometrial carcinoma: a new prognostic indicator.
        Am J Obstet Gynecol. 1996; 174: 1879-1884
        • Hollingsworth HC
        • Kihn EC
        • Steinberg SM
        • Rothenberg ML
        • Merino MJ.
        Tumor angiogenesis in advanced stage ovarian carcinoma.
        Am J Pathol. 1995; 147: 33-41
        • International Federation of Gynecology and Obstetrics cancer committee
        Staging announcement.
        Gynecol Oncol. 1986; 26: 383
        • Mietinnen M
        • Lindenmyer AE
        • Chaubal A.
        Endothelial cell marker CD31, CD34, BNH9 antibody to H- and Y- antigen: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
        Mod Pathol. 1994; 7: 82-90
        • DiSaia PJ
        • Creaseman WT
        Epithelial ovarian cancer.
        in: Clinical oncology. Mosby–Year Book, St. Louis1993: 333-425
        • Ishiwata I
        • Ishiwata C
        • Soma M
        • Ono I
        • Nakaguchi T
        • Ishikawa H.
        Tumor angiogenic activity of gynecologic tumor cell lines on the chorioallantoic membrane.
        Gynecol Oncol. 1988; 29: 87-93
        • Boocock CA
        • Charnock-Jones S
        • Sharkey AM
        • McLaren J
        • Barker PJ
        • Wright KA
        • et al.
        Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
        J Natl Cancer Inst. 1995; 87: 506-516
        • Wu CC
        • Lee CN
        • Chen TM
        • Shyu MK
        • Hsieh CY
        • Chen HY
        • et al.
        Incremental angiogenesis assessed by color Doppler ultrasound in the tumorigenesis of ovarian neoplasms.
        Cancer. 1994; 73: 1251-1256
        • Appleton MAC
        • Attanoos RL
        • Jasani B.
        Thrombomodulin as a marker of vascular and lymphatic tumours.
        Histopathology. 1996; 29: 153-157
        • Kenemans P
        • Yedema CA
        • Bon GG
        • von Mensdorff-Pouilly S
        CA-125 in gynecological pathology—a review.
        Eur J Obstet Gynecol Reprod Biol. 1993; 49: 115-124